• Something wrong with this record ?

Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril

S. Aziriova, K. Repova Bednarova, K. Krajcirovicova, J. Hrenak, R. Rajkovicova, K. Arendasova, N. Kamodyova, P. Celec, S. Zorad, M. Adamcova, L. Paulis, F. Simko,

. 2014 ; 124 (-) : 284-9.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc15023294

OBJECTIVE: Doxorubicin is a recognized chemotherapeutic agent widely employed in human malignancies. The limiting factor of its use is a number of side effects. The aim of this work was to show, whether administration of doxorubicin could induce behavioral disturbances in rats, and whether angiotensin-converting enzyme inhibitor captopril or melatonin can modify these potential alterations. DESIGN AND METHODS: Four groups of 3-month-old Wistar rats (twelve per group) were treated for 4 weeks: control (placebo-treated), doxorubicin (DOX) (5mg/kg i.v. in a single intravenous dose), DOX rats treated with either melatonin (10mg/kg/24h) or captopril (100mg/kg/24h). Systolic blood pressure (SBP) and the level of oxidative stress were investigated and behavioral tests of anxiety-open field test (OF), elevated plus maze (EPM) and light-dark box (LDB) were accomplished. RESULTS: Doxorubicin increased significantly systolic blood pressure and parameters of oxidative stress. Moreover, doxorubicin enhanced the level of anxiety in the tests of OF, EPM, and LDB. Captopril and melatonin prevented the blood pressure rise and the enhancement of oxidative load. Importantly, both substances reduced the parameters of anxiety. CONCLUSION: Chronic administration of captopril or melatonin has shown anxiolytic effect in the model of doxorubicin-induced anxiety. It does not seem unreasonable to suppose that this protective effect of captopril or melatonin against anxiety development might have been related to the antioxidative effects of both substances.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023294
003      
CZ-PrNML
005      
20231121090702.0
007      
ta
008      
150709s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.pbb.2014.06.021 $2 doi
035    __
$a (PubMed)24983779
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Aziriova, S $u Department of Pathophysiology, School of Medicine, Comenius University, Bratislava, Slovak Republic. $7 gn_A_00010713
245    10
$a Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril / $c S. Aziriova, K. Repova Bednarova, K. Krajcirovicova, J. Hrenak, R. Rajkovicova, K. Arendasova, N. Kamodyova, P. Celec, S. Zorad, M. Adamcova, L. Paulis, F. Simko,
520    9_
$a OBJECTIVE: Doxorubicin is a recognized chemotherapeutic agent widely employed in human malignancies. The limiting factor of its use is a number of side effects. The aim of this work was to show, whether administration of doxorubicin could induce behavioral disturbances in rats, and whether angiotensin-converting enzyme inhibitor captopril or melatonin can modify these potential alterations. DESIGN AND METHODS: Four groups of 3-month-old Wistar rats (twelve per group) were treated for 4 weeks: control (placebo-treated), doxorubicin (DOX) (5mg/kg i.v. in a single intravenous dose), DOX rats treated with either melatonin (10mg/kg/24h) or captopril (100mg/kg/24h). Systolic blood pressure (SBP) and the level of oxidative stress were investigated and behavioral tests of anxiety-open field test (OF), elevated plus maze (EPM) and light-dark box (LDB) were accomplished. RESULTS: Doxorubicin increased significantly systolic blood pressure and parameters of oxidative stress. Moreover, doxorubicin enhanced the level of anxiety in the tests of OF, EPM, and LDB. Captopril and melatonin prevented the blood pressure rise and the enhancement of oxidative load. Importantly, both substances reduced the parameters of anxiety. CONCLUSION: Chronic administration of captopril or melatonin has shown anxiolytic effect in the model of doxorubicin-induced anxiety. It does not seem unreasonable to suppose that this protective effect of captopril or melatonin against anxiety development might have been related to the antioxidative effects of both substances.
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorová antibiotika $x farmakologie $7 D000903
650    _2
$a chování zvířat $x účinky léků $7 D001522
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a krevní tlak $x účinky léků $7 D001794
650    _2
$a kaptopril $x farmakologie $7 D002216
650    _2
$a doxorubicin $x farmakologie $7 D004317
650    _2
$a antagonismus léků $7 D004336
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a melatonin $x farmakologie $7 D008550
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Repova Bednarova, K $u Department of Pathophysiology, School of Medicine, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Krajcirovicova, K $u Department of Pathophysiology, School of Medicine, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Hrenak, J $u Department of Pathophysiology, School of Medicine, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Rajkovicova, R $u Department of Pathophysiology, School of Medicine, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Arendasova, K $u Department of Pathophysiology, School of Medicine, Comenius University, Bratislava, Slovak Republic. $7 gn_A_00008254
700    1_
$a Kamodyova, N $u Institute of Molecular Biomedicine, School of Medicine, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Celec, P $u Department of Pathophysiology, School of Medicine, Comenius University, Bratislava, Slovak Republic; Institute of Molecular Biomedicine, School of Medicine, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Zorad, Štefan, $d 1956- $u Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic. $7 xx0310348
700    1_
$a Adamcova, M $u Department of Physiology, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic. $7 gn_A_00001173
700    1_
$a Paulis, L $u Department of Pathophysiology, School of Medicine, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Simko, F $u Department of Pathophysiology, School of Medicine, Comenius University, Bratislava, Slovak Republic; Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic; 3rd Clinic of Medicine, School of Medicine, Comenius University, Bratislava, Slovak Republic; Center of Excellence, NOREG, Slovak Republic. Electronic address: fedor.simko@fmed.uniba.sk.
773    0_
$w MED00003794 $t Pharmacology, biochemistry and behavior $x 1873-5177 $g Roč. 124, č. - (2014), s. 284-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24983779 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20231121090659 $b ABA008
999    __
$a ok $b bmc $g 1083632 $s 906287
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 124 $c - $d 284-9 $i 1873-5177 $m Pharmacology, biochemistry and behavior $n Pharmacol Biochem Behav $x MED00003794
LZP    __
$a Pubmed-20150709
Back

Find record

Citation metrics

Archiving options